quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:00:00·752d
PRRelease
Aquestive Therapeutics Inc. logo
Emergent BioSolutions Inc. logo
Gamida Cell Ltd. logo

Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive

AQST· Aquestive Therapeutics Inc.EBS· Emergent BioSolutions Inc.GMDA· Gamida Cell Ltd.
Health Care
Original source

Companies

  • AQST
    Aquestive Therapeutics Inc.
    Health Care
  • EBS
    Emergent BioSolutions Inc.
    Health Care
  • GMDA
    Gamida Cell Ltd.
    Health Care

Recent analyst ratings

  • Jun 2AQSTUpdateOppenheimer$7.00
  • Dec 30EBSUpdateH.C. Wainwright$15.00
  • Dec 17AQSTUpdateCantor Fitzgerald$17.00
  • Aug 22EBSUpdateRodman & Renshaw$16.00
  • May 10AQSTUpdateLeerink Partners$8.00
  • Apr 11AQSTUpdatePiper Sandler$10.00

Related

  • SEC1d
    SEC Form DEFA14A filed by Emergent BioSolutions Inc.
  • PR7d
    Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibility
  • PR7d
    Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026
  • SEC7d
    SEC Form DEFA14A filed by Emergent BioSolutions Inc.
  • SEC7d
    SEC Form DEFA14A filed by Emergent BioSolutions Inc.
  • INSIDER10d
    SEC Form 4 filed by Barber Daniel
  • INSIDER10d
    SEC Form 4 filed by Boyd Peter E.
  • INSIDER10d
    SEC Form 4 filed by Jung Cassie
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022